Structure

Physi-Chem Properties

Molecular Weight:  544.16
Volume:  520.44
LogP:  1.79
LogD:  1.281
LogS:  -2.908
# Rotatable Bonds:  10
TPSA:  189.28
# H-Bond Aceptor:  12
# H-Bond Donor:  5
# Rings:  4
# Heavy Atoms:  12

MedChem Properties

QED Drug-Likeness Score:  0.172
Synthetic Accessibility Score:  4.383
Fsp3:  0.37
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.029
MDCK Permeability:  2.582785782578867e-05
Pgp-inhibitor:  0.005
Pgp-substrate:  0.02
Human Intestinal Absorption (HIA):  0.549
20% Bioavailability (F20%):  0.822
30% Bioavailability (F30%):  0.982

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.205
Plasma Protein Binding (PPB):  94.04195404052734%
Volume Distribution (VD):  0.602
Pgp-substrate:  5.464143753051758%

ADMET: Metabolism

CYP1A2-inhibitor:  0.064
CYP1A2-substrate:  0.082
CYP2C19-inhibitor:  0.024
CYP2C19-substrate:  0.097
CYP2C9-inhibitor:  0.038
CYP2C9-substrate:  0.216
CYP2D6-inhibitor:  0.161
CYP2D6-substrate:  0.092
CYP3A4-inhibitor:  0.212
CYP3A4-substrate:  0.272

ADMET: Excretion

Clearance (CL):  2.321
Half-life (T1/2):  0.945

ADMET: Toxicity

hERG Blockers:  0.03
Human Hepatotoxicity (H-HT):  0.059
Drug-inuced Liver Injury (DILI):  0.965
AMES Toxicity:  0.516
Rat Oral Acute Toxicity:  0.029
Maximum Recommended Daily Dose:  0.002
Skin Sensitization:  0.031
Carcinogencity:  0.321
Eye Corrosion:  0.003
Eye Irritation:  0.234
Respiratory Toxicity:  0.008

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC71780

Natural Product ID:  NPC71780
Common Name*:   Cochinchiside B
IUPAC Name:   [(2S,3R,4S,5S,6R)-4,5-dihydroxy-2-[2-hydroxy-6-[(1-hydroxy-6-oxocyclohex-2-ene-1-carbonyl)oxymethyl]phenoxy]-6-(hydroxymethyl)oxan-3-yl] benzoate
Synonyms:  
Standard InCHIKey:  KAXLSURJPZQJPA-KELFPRCHSA-N
Standard InCHI:  InChI=1S/C27H28O12/c28-13-18-20(31)21(32)23(38-24(33)15-7-2-1-3-8-15)25(37-18)39-22-16(9-6-10-17(22)29)14-36-26(34)27(35)12-5-4-11-19(27)30/h1-3,5-10,12,18,20-21,23,25,28-29,31-32,35H,4,11,13-14H2/t18-,20-,21+,23-,25+,27?/m1/s1
SMILES:  c1ccc(cc1)C(=O)O[C@@H]1[C@H]([C@@H]([C@@H](CO)O[C@H]1Oc1c(cccc1O)COC(=O)C1(C=CCCC1=O)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL463281
PubChem CID:   10370160
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0004603] Organic oxygen compounds
      • [CHEMONTID:0000323] Organooxygen compounds
        • [CHEMONTID:0000011] Carbohydrates and carbohydrate conjugates
          • [CHEMONTID:0002105] Glycosyl compounds
            • [CHEMONTID:0004165] Phenolic glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO30966 Homalium cochinchinensis Species Salicaceae Eukaryota n.a. n.a. n.a. PMID[15104498]
NPO30966 Homalium cochinchinensis Species Salicaceae Eukaryota n.a. n.a. n.a. PMID[9584406]
NPO30966 Homalium cochinchinensis Species Salicaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO26516 Homalium cochinchinense Species Salicaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO26516 Homalium cochinchinense Species Salicaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT190 Organism Human herpesvirus 1 Human herpesvirus 1 EC50 = 76000.0 nM PMID[529907]
NPT1141 Organism Human herpesvirus 2 Human herpesvirus 2 EC50 = 76000.0 nM PMID[529907]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 EC50 > 18000.0 nM PMID[529907]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC71780 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9545 High Similarity NPC474398
0.9545 High Similarity NPC474401
0.9545 High Similarity NPC476026
0.9545 High Similarity NPC474441
0.9408 High Similarity NPC131874
0.9359 High Similarity NPC57072
0.9359 High Similarity NPC231475
0.9342 High Similarity NPC471214
0.9276 High Similarity NPC22137
0.9245 High Similarity NPC475183
0.913 High Similarity NPC475174
0.9068 High Similarity NPC280923
0.9024 High Similarity NPC153755
0.9012 High Similarity NPC197285
0.9012 High Similarity NPC21100
0.9 High Similarity NPC217950
0.8981 High Similarity NPC92153
0.8981 High Similarity NPC299761
0.8981 High Similarity NPC230439
0.8981 High Similarity NPC279281
0.897 High Similarity NPC4390
0.8963 High Similarity NPC149011
0.8963 High Similarity NPC116864
0.8963 High Similarity NPC204937
0.8963 High Similarity NPC20505
0.8963 High Similarity NPC155763
0.8963 High Similarity NPC235260
0.8963 High Similarity NPC206123
0.8963 High Similarity NPC244776
0.8961 High Similarity NPC92054
0.8961 High Similarity NPC140722
0.8961 High Similarity NPC4958
0.8957 High Similarity NPC116745
0.8951 High Similarity NPC277205
0.8922 High Similarity NPC217520
0.8922 High Similarity NPC139571
0.8916 High Similarity NPC477848
0.8916 High Similarity NPC237435
0.8916 High Similarity NPC115760
0.8916 High Similarity NPC81042
0.8916 High Similarity NPC49344
0.8916 High Similarity NPC214621
0.8916 High Similarity NPC135277
0.8916 High Similarity NPC43211
0.8916 High Similarity NPC210094
0.8916 High Similarity NPC223426
0.8916 High Similarity NPC34267
0.8916 High Similarity NPC101191
0.891 High Similarity NPC93619
0.8909 High Similarity NPC190003
0.8909 High Similarity NPC175107
0.8903 High Similarity NPC111785
0.8902 High Similarity NPC472133
0.8902 High Similarity NPC225434
0.8902 High Similarity NPC203050
0.8902 High Similarity NPC223747
0.8902 High Similarity NPC138927
0.8902 High Similarity NPC120099
0.8902 High Similarity NPC219904
0.8896 High Similarity NPC145038
0.8896 High Similarity NPC474422
0.8896 High Similarity NPC274618
0.8896 High Similarity NPC253662
0.8896 High Similarity NPC281131
0.8896 High Similarity NPC56077
0.8896 High Similarity NPC88789
0.8896 High Similarity NPC276222
0.8896 High Similarity NPC179950
0.8896 High Similarity NPC308404
0.8896 High Similarity NPC118284
0.8889 High Similarity NPC270335
0.8889 High Similarity NPC168822
0.8889 High Similarity NPC88043
0.8889 High Similarity NPC127415
0.8889 High Similarity NPC191306
0.8868 High Similarity NPC471405
0.8862 High Similarity NPC268533
0.8862 High Similarity NPC472385
0.8862 High Similarity NPC198324
0.8862 High Similarity NPC211532
0.8862 High Similarity NPC144097
0.8862 High Similarity NPC61904
0.8862 High Similarity NPC233994
0.8861 High Similarity NPC191046
0.8861 High Similarity NPC194095
0.8861 High Similarity NPC327032
0.8855 High Similarity NPC88560
0.8855 High Similarity NPC172033
0.8855 High Similarity NPC472993
0.8855 High Similarity NPC175230
0.8848 High Similarity NPC245014
0.8848 High Similarity NPC285197
0.8848 High Similarity NPC43434
0.8848 High Similarity NPC72249
0.8848 High Similarity NPC84265
0.8848 High Similarity NPC472129
0.8848 High Similarity NPC280385
0.8848 High Similarity NPC282987
0.8841 High Similarity NPC229729
0.8841 High Similarity NPC265530
0.8841 High Similarity NPC52550
0.8841 High Similarity NPC173637
0.8841 High Similarity NPC84362
0.8841 High Similarity NPC160156
0.8841 High Similarity NPC298847
0.8841 High Similarity NPC317489
0.8841 High Similarity NPC45400
0.8841 High Similarity NPC149244
0.8841 High Similarity NPC127546
0.8841 High Similarity NPC226304
0.8841 High Similarity NPC325555
0.8841 High Similarity NPC48640
0.8841 High Similarity NPC92565
0.8841 High Similarity NPC223424
0.8834 High Similarity NPC240431
0.8834 High Similarity NPC472130
0.8834 High Similarity NPC22832
0.8834 High Similarity NPC472131
0.8834 High Similarity NPC165720
0.8834 High Similarity NPC19388
0.8834 High Similarity NPC55786
0.8834 High Similarity NPC311830
0.8827 High Similarity NPC189142
0.8827 High Similarity NPC77660
0.8827 High Similarity NPC22324
0.882 High Similarity NPC44507
0.8817 High Similarity NPC170203
0.8816 High Similarity NPC31081
0.8816 High Similarity NPC245219
0.8812 High Similarity NPC40920
0.8812 High Similarity NPC223335
0.8812 High Similarity NPC133984
0.881 High Similarity NPC113836
0.881 High Similarity NPC37668
0.881 High Similarity NPC35167
0.881 High Similarity NPC173837
0.881 High Similarity NPC253521
0.881 High Similarity NPC477895
0.8805 High Similarity NPC10205
0.8802 High Similarity NPC264735
0.8802 High Similarity NPC253685
0.8797 High Similarity NPC215811
0.8797 High Similarity NPC157898
0.8795 High Similarity NPC60735
0.8795 High Similarity NPC254540
0.8795 High Similarity NPC67134
0.8795 High Similarity NPC211594
0.8795 High Similarity NPC117260
0.8795 High Similarity NPC476405
0.8795 High Similarity NPC26230
0.8795 High Similarity NPC245452
0.8795 High Similarity NPC235575
0.8795 High Similarity NPC172807
0.8795 High Similarity NPC47140
0.8788 High Similarity NPC52382
0.8788 High Similarity NPC229687
0.8788 High Similarity NPC270578
0.878 High Similarity NPC135599
0.878 High Similarity NPC113968
0.878 High Similarity NPC236934
0.878 High Similarity NPC328940
0.878 High Similarity NPC5778
0.878 High Similarity NPC254306
0.878 High Similarity NPC73855
0.878 High Similarity NPC277174
0.8773 High Similarity NPC121290
0.8773 High Similarity NPC309025
0.8773 High Similarity NPC222936
0.8773 High Similarity NPC29830
0.8773 High Similarity NPC284960
0.8773 High Similarity NPC243930
0.8773 High Similarity NPC88023
0.8773 High Similarity NPC19709
0.8765 High Similarity NPC470718
0.8765 High Similarity NPC36138
0.8758 High Similarity NPC469654
0.8758 High Similarity NPC160780
0.8758 High Similarity NPC289811
0.875 High Similarity NPC296018
0.875 High Similarity NPC472384
0.875 High Similarity NPC471669
0.875 High Similarity NPC472382
0.875 High Similarity NPC472991
0.875 High Similarity NPC154741
0.875 High Similarity NPC472380
0.875 High Similarity NPC89127
0.875 High Similarity NPC472992
0.8743 High Similarity NPC45522
0.8743 High Similarity NPC101026
0.8743 High Similarity NPC24043
0.8743 High Similarity NPC42773
0.8743 High Similarity NPC470438
0.8743 High Similarity NPC169977
0.8743 High Similarity NPC21666
0.8742 High Similarity NPC299435
0.8742 High Similarity NPC260604
0.8742 High Similarity NPC185103
0.8735 High Similarity NPC259896
0.8735 High Similarity NPC471416
0.8735 High Similarity NPC255157

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC71780 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8916 High Similarity NPD4338 Clinical (unspecified phase)
0.8683 High Similarity NPD6797 Phase 2
0.8675 High Similarity NPD7054 Approved
0.8631 High Similarity NPD7251 Discontinued
0.8623 High Similarity NPD7472 Approved
0.8623 High Similarity NPD7074 Phase 3
0.8614 High Similarity NPD3818 Discontinued
0.858 High Similarity NPD7808 Phase 3
0.8466 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8383 Intermediate Similarity NPD6166 Phase 2
0.8383 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8383 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8344 Intermediate Similarity NPD5402 Approved
0.8293 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.825 Intermediate Similarity NPD5403 Approved
0.8232 Intermediate Similarity NPD3817 Phase 2
0.8221 Intermediate Similarity NPD1934 Approved
0.8199 Intermediate Similarity NPD1653 Approved
0.814 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8129 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8125 Intermediate Similarity NPD5401 Approved
0.8103 Intermediate Similarity NPD8313 Approved
0.8103 Intermediate Similarity NPD8312 Approved
0.8092 Intermediate Similarity NPD6559 Discontinued
0.8092 Intermediate Similarity NPD7685 Pre-registration
0.8072 Intermediate Similarity NPD3882 Suspended
0.8061 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8052 Intermediate Similarity NPD1933 Approved
0.8024 Intermediate Similarity NPD7075 Discontinued
0.7989 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7965 Intermediate Similarity NPD3751 Discontinued
0.7963 Intermediate Similarity NPD1512 Approved
0.7952 Intermediate Similarity NPD2801 Approved
0.7911 Intermediate Similarity NPD7266 Discontinued
0.7879 Intermediate Similarity NPD4380 Phase 2
0.7844 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.784 Intermediate Similarity NPD1511 Approved
0.7826 Intermediate Similarity NPD6190 Approved
0.7821 Intermediate Similarity NPD447 Suspended
0.7809 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7784 Intermediate Similarity NPD6801 Discontinued
0.7778 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7738 Intermediate Similarity NPD1465 Phase 2
0.7733 Intermediate Similarity NPD3787 Discontinued
0.773 Intermediate Similarity NPD6799 Approved
0.7714 Intermediate Similarity NPD5844 Phase 1
0.7657 Intermediate Similarity NPD7228 Approved
0.7633 Intermediate Similarity NPD8455 Phase 2
0.7625 Intermediate Similarity NPD1551 Phase 2
0.759 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7566 Intermediate Similarity NPD7435 Discontinued
0.7558 Intermediate Similarity NPD6234 Discontinued
0.7546 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7546 Intermediate Similarity NPD3750 Approved
0.7532 Intermediate Similarity NPD1203 Approved
0.7531 Intermediate Similarity NPD1549 Phase 2
0.7529 Intermediate Similarity NPD7819 Suspended
0.7515 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7515 Intermediate Similarity NPD7411 Suspended
0.7514 Intermediate Similarity NPD5494 Approved
0.75 Intermediate Similarity NPD6779 Approved
0.75 Intermediate Similarity NPD6781 Approved
0.75 Intermediate Similarity NPD6776 Approved
0.75 Intermediate Similarity NPD6780 Approved
0.75 Intermediate Similarity NPD6778 Approved
0.75 Intermediate Similarity NPD1091 Approved
0.75 Intermediate Similarity NPD6782 Approved
0.75 Intermediate Similarity NPD6777 Approved
0.7486 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7473 Intermediate Similarity NPD8150 Discontinued
0.7471 Intermediate Similarity NPD7199 Phase 2
0.7471 Intermediate Similarity NPD37 Approved
0.747 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7469 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7469 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7456 Intermediate Similarity NPD6599 Discontinued
0.7442 Intermediate Similarity NPD4965 Approved
0.7442 Intermediate Similarity NPD4966 Approved
0.7442 Intermediate Similarity NPD4967 Phase 2
0.7439 Intermediate Similarity NPD4628 Phase 3
0.7429 Intermediate Similarity NPD6232 Discontinued
0.7421 Intermediate Similarity NPD1613 Approved
0.7421 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7407 Intermediate Similarity NPD2935 Discontinued
0.7401 Intermediate Similarity NPD7473 Discontinued
0.7396 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7389 Intermediate Similarity NPD6832 Phase 2
0.7377 Intermediate Similarity NPD8434 Phase 2
0.7375 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7365 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD7874 Approved
0.7296 Intermediate Similarity NPD2313 Discontinued
0.7294 Intermediate Similarity NPD3226 Approved
0.7292 Intermediate Similarity NPD7696 Phase 3
0.7292 Intermediate Similarity NPD7697 Approved
0.7292 Intermediate Similarity NPD7698 Approved
0.729 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7283 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD230 Phase 1
0.7262 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7257 Intermediate Similarity NPD919 Approved
0.7256 Intermediate Similarity NPD2346 Discontinued
0.7254 Intermediate Similarity NPD7870 Phase 2
0.7254 Intermediate Similarity NPD7871 Phase 2
0.7247 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD7768 Phase 2
0.724 Intermediate Similarity NPD6823 Phase 2
0.7239 Intermediate Similarity NPD1510 Phase 2
0.7239 Intermediate Similarity NPD3748 Approved
0.7239 Intermediate Similarity NPD7033 Discontinued
0.7234 Intermediate Similarity NPD6535 Approved
0.7234 Intermediate Similarity NPD6534 Approved
0.7231 Intermediate Similarity NPD7701 Phase 2
0.7229 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7226 Intermediate Similarity NPD9717 Approved
0.72 Intermediate Similarity NPD3749 Approved
0.7198 Intermediate Similarity NPD7240 Approved
0.7195 Intermediate Similarity NPD2796 Approved
0.7191 Intermediate Similarity NPD3926 Phase 2
0.7188 Intermediate Similarity NPD6798 Discontinued
0.7175 Intermediate Similarity NPD6959 Discontinued
0.717 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7165 Intermediate Similarity NPD8320 Phase 1
0.7165 Intermediate Similarity NPD8319 Approved
0.7161 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD6233 Phase 2
0.7134 Intermediate Similarity NPD4308 Phase 3
0.7134 Intermediate Similarity NPD3225 Approved
0.7125 Intermediate Similarity NPD3027 Phase 3
0.7121 Intermediate Similarity NPD7801 Approved
0.7121 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7121 Intermediate Similarity NPD7783 Phase 2
0.712 Intermediate Similarity NPD7700 Phase 2
0.712 Intermediate Similarity NPD7699 Phase 2
0.7107 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD8151 Discontinued
0.7093 Intermediate Similarity NPD7458 Discontinued
0.7092 Intermediate Similarity NPD7584 Approved
0.7081 Intermediate Similarity NPD411 Approved
0.7079 Intermediate Similarity NPD8127 Discontinued
0.7073 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.7069 Intermediate Similarity NPD6844 Discontinued
0.7066 Intermediate Similarity NPD6674 Discontinued
0.7056 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD6355 Discontinued
0.7044 Intermediate Similarity NPD2798 Approved
0.703 Intermediate Similarity NPD2799 Discontinued
0.7011 Intermediate Similarity NPD7038 Approved
0.7011 Intermediate Similarity NPD7039 Approved
0.7006 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD9494 Approved
0.6994 Remote Similarity NPD1240 Approved
0.6994 Remote Similarity NPD943 Approved
0.6983 Remote Similarity NPD1247 Approved
0.6981 Remote Similarity NPD2797 Approved
0.6979 Remote Similarity NPD8090 Clinical (unspecified phase)
0.6976 Remote Similarity NPD8155 Clinical (unspecified phase)
0.6975 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6975 Remote Similarity NPD3268 Approved
0.697 Remote Similarity NPD7585 Approved
0.6937 Remote Similarity NPD1019 Discontinued
0.6919 Remote Similarity NPD7583 Approved
0.6911 Remote Similarity NPD6212 Phase 3
0.6911 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6911 Remote Similarity NPD6213 Phase 3
0.6909 Remote Similarity NPD1607 Approved
0.6907 Remote Similarity NPD7237 Clinical (unspecified phase)
0.689 Remote Similarity NPD4307 Phase 2
0.689 Remote Similarity NPD4060 Phase 1
0.6885 Remote Similarity NPD2163 Approved
0.6883 Remote Similarity NPD9493 Approved
0.6867 Remote Similarity NPD4978 Clinical (unspecified phase)
0.6867 Remote Similarity NPD7097 Phase 1
0.6853 Remote Similarity NPD7680 Approved
0.6839 Remote Similarity NPD5536 Phase 2
0.6829 Remote Similarity NPD4062 Phase 3
0.6826 Remote Similarity NPD651 Clinical (unspecified phase)
0.6824 Remote Similarity NPD8166 Discontinued
0.6821 Remote Similarity NPD5049 Phase 3
0.6821 Remote Similarity NPD6273 Approved
0.6818 Remote Similarity NPD6386 Approved
0.6818 Remote Similarity NPD6385 Approved
0.681 Remote Similarity NPD7095 Approved
0.68 Remote Similarity NPD3455 Phase 2
0.6798 Remote Similarity NPD5353 Approved
0.6793 Remote Similarity NPD7799 Discontinued
0.6792 Remote Similarity NPD1608 Approved
0.6786 Remote Similarity NPD6099 Approved
0.6786 Remote Similarity NPD6100 Approved
0.6784 Remote Similarity NPD2354 Approved
0.6784 Remote Similarity NPD3887 Approved
0.6774 Remote Similarity NPD5953 Discontinued
0.6769 Remote Similarity NPD4420 Approved
0.6768 Remote Similarity NPD3764 Approved
0.6765 Remote Similarity NPD1652 Phase 2
0.6765 Remote Similarity NPD7930 Approved
0.6763 Remote Similarity NPD4662 Approved
0.6763 Remote Similarity NPD2533 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data